摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-(Bromomethyl)-2,2,6-trimethyl-1,3-dioxin-4-one | 114473-84-6

中文名称
——
中文别名
——
英文名称
5-(Bromomethyl)-2,2,6-trimethyl-1,3-dioxin-4-one
英文别名
——
5-(Bromomethyl)-2,2,6-trimethyl-1,3-dioxin-4-one化学式
CAS
114473-84-6
化学式
C8H11BrO3
mdl
——
分子量
235.078
InChiKey
UASKPQFPFDROBY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    289.1±40.0 °C(Predicted)
  • 密度:
    1.407±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.62
  • 拓扑面积:
    35.5
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    5-(Bromomethyl)-2,2,6-trimethyl-1,3-dioxin-4-one 在 palladium on activated charcoal 氢气 、 sodium hydride 、 蔗糖 作用下, 以 甲醇 为溶剂, 25.0~32.0 ℃ 、101.33 kPa 条件下, 反应 16.0h, 生成 5-(3-Hydroxybutyl)-2,2,6-trimethyl-1,3-dioxin-4-one
    参考文献:
    名称:
    Synthesis of 1,3-dioxin-4-ones having chiral hydroxyalkyl groups at the 6-position by means of baker's yeast reduction and their uses for epc synthesis
    摘要:
    Prochiral methyl ketones connected with 6-(4-oxo-1,3-dioxinyl) group directly or through methylene chain (1-3) gave, by treatment with fermenting baker's yeast, the corresponding (S)-alcohols which served as synthons for a variety of enantiomerically pure compounds.
    DOI:
    10.1016/s0040-4020(01)86552-2
  • 作为产物:
    参考文献:
    名称:
    Synthesis of 1,3-dioxin-4-ones having chiral hydroxyalkyl groups at the 6-position by means of baker's yeast reduction and their uses for epc synthesis
    摘要:
    Prochiral methyl ketones connected with 6-(4-oxo-1,3-dioxinyl) group directly or through methylene chain (1-3) gave, by treatment with fermenting baker's yeast, the corresponding (S)-alcohols which served as synthons for a variety of enantiomerically pure compounds.
    DOI:
    10.1016/s0040-4020(01)86552-2
点击查看最新优质反应信息

文献信息

  • DC 107 DERIVATIVES (2)
    申请人:Kyowa Hakko Kogyo Co., Ltd.
    公开号:EP0887351A1
    公开(公告)日:1998-12-30
    DC107 derivatives represented by formula (I) or pharmaceutically acceptable salts thereof which have antimicrobial activity and antitumor activity are provided: wherein R1 represents CO(CR4AR4B)n1(O(CH2)p1)n2OR5 wherein n1 represents an integer of 1 or 2; R4A and R4B are the same or different, and each represents hydrogen or lower alkyl; p1 and n2 each represents an integer of 1 to 10; and R5 represents hydrogen, lower alkyl, or the like), or (wherein A1, A2, A3, and A4 are the same or different, and each represents hydrogen, hydroxy, or the like); R2 represents hydrogen or COR6 (wherein R6 represents lower alkyl, aralkyl, substituted or unsubstituted aryl, or the like); R3 represents lower alkyl, lower alkenyl, aralkyl having substituted or unsubstituted aryl, alicyclic alkanoyloxyalkyl, -CH2OCOR7, or the like, or is combined with Y to represent a bond; Y is combined together with R3 to represent a bond or is combined together with Z to represent a bond; Z represents hydrogen, or is combined together with Y to represent a bond; and W represents oxygen, or NR8.
    提供了具有抗菌活性和抗肿瘤活性的式 (I) 所代表的 DC107 衍生物或其药学上可接受的盐: 其中 R1 代表 CO(CR4AR4B)n1(O(CH2)p1)n2OR5 其中 n1 代表 1 或 2 的整数;R4A 和 R4B 相同或不同,且各自代表氢或低级烷基;p1 和 n2 各自代表 1 至 10 的整数;以及 R5 代表氢、低级烷基或类似物),或 (其中 A1、A2、A3 和 A4 相同或不同,且各自代表氢、羟基或类似物); R2 代表氢或 COR6(其中 R6 代表低级烷基、芳基、取代或未取代的芳基或类似物);R3 代表低级烷基、低级烯基、具有取代或未取代芳基的烷基、脂环烷氧基烷基、- OCOR7 或类似物,或与 Y 结合代表键;Y 与 R3 结合代表键,或与 Z 结合代表键;Z 代表氢,或与 Y 结合代表键;W 代表氧或 NR8。
  • DC 107 DERIVATIVES (1)
    申请人:KYOWA HAKKO KOGYO CO., Ltd.
    公开号:EP0918058A1
    公开(公告)日:1999-05-26
    DC107 derivatives represented by formula (I) or pharmaceutically acceptable salts thereof which have antimicrobial activity and antitumor activity are provided: wherein R1 represents hydrogen, lower alkoxyalkyl, aralkyloxyalkyl, lower alkoxyalkoxyalkyl, lower alkoxyalkoxyalkoxyalkyl, aralkyl, tetrahydropyranyl, COR4, or the like; R2 represents hydrogen or COR6; R3 represents -CH2OCOR7, phthalimidomethyl, or the like; and W represents oxygen or NR8 (wherein R8 represents hydroxy, lower alkoxy, lower alkenyloxy, aralkyloxy, substituted or unsubstituted arylsulfonylamino, or lower alkoxycarbonylamino).
    提供了具有抗菌活性和抗肿瘤活性的式 (I) 所代表的 DC107 衍生物或其药学上可接受的盐: 其中 R1 代表氢、低级烷氧基烷基、芳氧基烷基、低级烷氧基烷氧基烷基、低级烷氧基烷氧基烷基、芳基、四氢吡喃基、COR4 或类似物;R2 代表氢或 COR6;R3 代表-CH2OCOR7、邻苯二甲酰亚胺基甲基或类似物;W 代表氧或 NR8(其中 R8 代表羟基、低级烷氧基、低级烯氧基、芳基氧基、取代或未取代的芳基磺酰基基或低级烷氧基羰基基)。
  • Sato, Masayuki; Ogasawara, Hiromichi; Takayama, Kazuhisa, Heterocycles, 1987, vol. 26, # 10, p. 2611 - 2614
    作者:Sato, Masayuki、Ogasawara, Hiromichi、Takayama, Kazuhisa、Kaneko, Chikara
    DOI:——
    日期:——
  • US5981558A
    申请人:——
    公开号:US5981558A
    公开(公告)日:1999-11-09
  • US6080771A
    申请人:——
    公开号:US6080771A
    公开(公告)日:2000-06-27
查看更多